首页> 外文期刊>BMC Pediatrics >Extraperitoneal pediatric kidney transplantation of adult renal allograft using an en-bloc native liver and kidney mobilization technique
【24h】

Extraperitoneal pediatric kidney transplantation of adult renal allograft using an en-bloc native liver and kidney mobilization technique

机译:使用en-Bloc天然肝肾动员技术的腹膜肾移植成人肾同种异体肾移植

获取原文
获取外文期刊封面目录资料

摘要

We describe the safety and efficacy of performing pediatric kidney transplantation with a modified extraperitoneal approach that includes mobilization of the native liver and kidney. We retrospectively identified pediatric renal transplants performed using this technique between 2015 and 2019. Data on patient demographics, surgical technique, and intraoperative details were collected. Outcomes were measured by morbidity and re-operation at 90 days, as well as serum creatinine, allograft survival, and overall survival at 1?year. Twenty-one patients with a median age of 5 (IQR 3–9) years, weighing 17.5 (IQR 14.5–24) kg were included. Median donor age was 24 (IQR 19–31) years. No intraoperative complications occurred. One child required a right native nephrectomy to allow sufficient space. Postoperatively, all patients had immediate graft function without urine leak or allograft thrombosis. 90-day morbidity and re-operation rates were zero. Both 1-year allograft and overall survival were 100% (on follow-up of all 21 patients through 1?year post-transplant), with a median serum creatinine of 0.58 (IQR 0.47–0.70) mg/dl at 1?year post-transplant. Pediatric kidney transplantation of adult renal allografts using an extraperitoneal approach with native liver and kidney mobilization has promising allograft and patient survival outcomes that eliminates peritoneal violation and may diminish the need for native nephrectomy.
机译:我们描述了用改性的腹膜肾移植进行小儿肾移植的安全性和疗效,包括动员天然肝和肾。我们回顾性地确定了在2015年和2019年之间使用该技术进行的儿科肾移植。收集了患者人口统计学,手术技术和术中细节的数据。结果是通过发病率并在90天的发病率并重新操作来测量,以及血清肌酐,同种异体移植生存和1年整体存活。 2名中位数5岁(IQR 3-9)年龄的二十一名患者,称重17.5(IQR 14.5-24)kg。中位数捐助年龄为24岁(IQR 19-31)年。没有发生术中并发症。一个孩子需要一个正确的本地肾切除术来允许足够的空间。术后,所有患者均无立即接枝功能而无需尿液或同种异体移植血栓形成。 90天的发病率和重新运营率为零。 1年同种异体移植和整体存活率均为100%(通过所有21例患者的后续行动通过1?年后移植后),中位血清肌酐为0.58(IQR 0.47-0.70)mg / dl,1?末期-移植。儿科肾移植成人肾同种异体移植物使用肝脏和肾动员的腹膜肾移植,具有令人欣慰的同种异体移植和患者存活结果,消除腹膜侵犯,并可能减少对本地肾病术的需求。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号